Dr Reddy's Q1 net profit sees six-fold growth to Rs 4.76 billion

The company has maintained visible control over the costs from manufacturing costs to general selling and R&D expenses for the second consecutive quarter

Dr Reddy's Laboratories Limited has reported more than a six-fold increase in consolidated net profit at Rs 4.56 billion for the quarter ended June 30, 2018, over an exceptionally lower base of Rs 0.6 billion in the corresponding quarter previous year. The profit came on the back of a turnaround helped by a combination of revenue growth and cost control.

Revenues grew 12 percent at Rs 37.21 billion as compared to Rs 33.16 billion in the year-ago period due to a healthy 30 per cent growth in Indian sales and a 16 per cent rise in revenue contribution from emerging markets